Skip to Main Content

Paper Details

Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM Complex.
Cancer Res
1
2023
AR, Androgen, Androgen Receptor, Androgens, DREAM, DREAM Complex, DREAM complex, E2F, E2F target genes, E2F targets, E2F1, MYC, RB-like, RB1, RBL1/2, SPA, Tumor, androgen, androgen receptor, androgens, cMYC, cistrome, metastatic prostate cancer, multivulval class B, patient, patients, prostate cancer, prostate cancers
Author NameAffiliation
Ilsa ColemanDivisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Center
Elahe A Mostagheland Clinical Center
Stephen R Plymateand Clinical Center
Eva CoreyUniversity of Washington
Michael C HaffnerDivisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Center
Michael C HaffnerUniversity of Washington
Peter S NelsonDivisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Center
Peter S NelsonUniversity of Washington
Peter S NelsonUniversity of Washington
Peter S NelsonUniversity of Washington
Peter S NelsonUniversity of Washington
Peter S NelsonDivisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Center
Peter S NelsonUniversity of Washington
Peter S NelsonUniversity of Washington
Peter S NelsonUniversity of Washington
Peter S NelsonUniversity of Washington
  • 1 - 16

Datasets

Release 1.2